BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 8637015)

  • 1. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
    Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study.
    De Simone G; Balliano G; Milla P; Gallina C; Giordano C; Tarricone C; Rizzi M; Bolognesi M; Ascenzi P
    J Mol Biol; 1997 Jun; 269(4):558-69. PubMed ID: 9217260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine proteinase inhibition by the active site titrant N alpha-(N, N-dimethylcarbamoyl)-alpha-azaornithine p-nitrophenyl ester. A comparative study.
    Ascenzi P; Balliano G; Gallina C; Polticelli F; Bolognesi M
    Eur J Biochem; 2000 Feb; 267(4):1239-46. PubMed ID: 10672036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester: a novel, high selective and optimal chromogenic active site titrant for human and bovine alpha-, beta- and gamma-thrombin.
    Balliano G; Milla P; Giordano C; Gallina C; Coletta M; Menegatti E; Rizzi M; Bolognesi M; Ascenzi P
    Biochem Biophys Res Commun; 1996 Aug; 225(2):557-61. PubMed ID: 8753800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active site titration of bovine beta-trypsin by N alpha-(N,N-dimethylcarbamoyl)-alpha-aza-lysine p-nitrophenyl ester: kinetic and crystallographic analysis.
    Sartori P; Djinovic Carugo K; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    FEBS Lett; 1995 Jan; 358(1):53-6. PubMed ID: 7821429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel natural product 5,5-trans-lactone inhibitors of human alpha-thrombin: mechanism of action and structural studies.
    Weir MP; Bethell SS; Cleasby A; Campbell CJ; Dennis RJ; Dix CJ; Finch H; Jhoti H; Mooney CJ; Patel S; Tang CM; Ward M; Wonacott AJ; Wharton CW
    Biochemistry; 1998 May; 37(19):6645-57. PubMed ID: 9578548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bovine beta-trypsin by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azaornithine p-nitrophenyl ester: a kinetic and X-ray crystallographic study.
    Ascenzi P; Balliano G; Milla P; Ferraccioli R; Sartori P; Djinovic-Carugo K; Bolognesi M
    Biochem Biophys Res Commun; 1995 Dec; 217(2):437-44. PubMed ID: 7503719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.
    Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M
    Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
    Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
    Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methyl group of N(alpha)(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage.
    Friedrich R; Steinmetzer T; Huber R; Stürzebecher J; Bode W
    J Mol Biol; 2002 Mar; 316(4):869-74. PubMed ID: 11884127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
    Skrzypczak-Jankun E; Carperos VE; Ravichandran KG; Tulinsky A; Westbrook M; Maraganore JM
    J Mol Biol; 1991 Oct; 221(4):1379-93. PubMed ID: 1942057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
    Bertrand JA; Oleksyszyn J; Kam CM; Boduszek B; Presnell S; Plaskon RR; Suddath FL; Powers JC; Williams LD
    Biochemistry; 1996 Mar; 35(10):3147-55. PubMed ID: 8605148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
    Ganesh V; Lee AY; Clardy J; Tulinsky A
    Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
    Chirgadze NY; Sall DJ; Klimkowski VJ; Clawson DK; Briggs SL; Hermann R; Smith GF; Gifford-Moore DS; Wery JP
    Protein Sci; 1997 Jul; 6(7):1412-7. PubMed ID: 9232642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxyanion-mediated inhibition of serine proteases.
    Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
    Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and inhibiting properties toward trypsin like proteases of N alpha-(N,N-dimethylcarbamoyl)-alpha-azaornitine and alpha-azalysine esters.
    Ferraccioli R; Croce PD; Gallina C; Consalvi V; Scandurra R
    Farmaco; 1991 Dec; 46(12):1517-31. PubMed ID: 1821631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.